Form 4: Guardant Health Director Meghan V. Joyce Reports Stock Transactions
SEC Form 4 Filing
Director Meghan V. Joyce of Guardant Health, Inc. reports the acquisition and disposal of common stock and restricted stock units on April 4, 2024.
Summary
- On April 4, 2024, Meghan V. Joyce, a director of Guardant Health, Inc., engaged in transactions involving the company's stock.
- Joyce acquired 67 shares of common stock through the vesting of restricted stock units.
- The price for the acquired common stock was $0.
- Following these transactions, Joyce directly owns 4,588 shares of common stock and 1,062 restricted stock units.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions by a company director. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.
Industry Context
This filing is a routine disclosure of stock transactions by a company insider, as required by the SEC. It provides transparency to the market regarding the actions of company directors.
Stakeholder Impact
- The filing provides transparency to shareholders regarding insider transactions.
Key Dates
| Date | Description |
|---|---|
| August 4, 2022 | Initial vesting date for 25% of the restricted stock units. |
| April 4, 2024 | Date of stock acquisition and disposal. |
| April 5, 2024 | Date of signature for the report. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.